Hb及HCT在先天性心脏病患儿围手术期管理及结局预测中的研究进展  

Research progress of Hb and HCT in perioperative management and outcome prediction of children with congenital heart disease

作　　者：刘一为 刘彩霞[2] Liu Yiwei;Liu Caixia(Department of Pediatrics,Shanxi Medical University,Taiyuan 030001,China;Department of Cardiothoracic Surgery,Shanxi Children's Hospital,Taiyuan 030025,China)

机构地区：[1]山西医科大学儿科医学系,太原030001 [2]山西省儿童医院心胸外科,太原030025

出　　处：《中华小儿外科杂志》2025年第3期264-268,共5页Chinese Journal of Pediatric Surgery

基　　金：山西省“四个一批”医学重点科研项目(2022XM20)。

摘　　要：先天性心脏病(congenital heart disease,CHD)是在胚胎发育期间出现的心脏或大血管的结构异常,占所有活产儿的1.0%,是所有出生缺陷中最常见的疾病。血红蛋白(hemoglobin,Hb)、红细胞比容(hematocrit,HCT)是临床上很常见的血液学指标。有研究发现围手术期的Hb及HCT对于体外循环CHD的预后有一定的预测价值。但在不同年龄段、不同CHD类型患儿中,由于Hb及HCT参考值不同,围手术期管理中的指导标准也不同。为了更好地指导临床工作,本文旨在对Hb及HCT的年龄变化特点、CHD患儿Hb及HCT的特点、围手术期Hb及HCT在CHD结局预测中的研究进展进行综述。Congenital heart disease(CHD)is a structural abnormality of the heart or large blood vessels that occurs during embryonic development.It accounts for 1.0%of all live births and is the most common of all birth defects.Hemoglobin(Hb)and hematocrit(HCT)are common hematological indexes in clinical practice.Some studies have found that perioperative Hb and HCT have certain predictive value in the prognosis of CHD after cardiopulmonary bypass.However,Hb and HCT reference values varied in children at various age groups and CHD types,leading to different perioperative management strategies.In order to better guide clinical practice,this article aimed to review the age-related changes of Hb and HCT,the characteristics of Hb and Hct in CHD children,and the research progress of perioperative Hb and HCT in the prediction of CHD outcome.

关 键 词：血红蛋白类 红细胞比容 先天性心脏病 

分 类 号：R726.5[医药卫生—儿科]